BHARAT IMMUNOLOGICALS & BIOLOG Share Price

₹ 9.19

+₹0.32 (3.61%)
1D
Last updated 02 Nov, 2026, 15:28 IST
BSE: 524663
|
Pharmaceuticals

BHARAT IMMUNOLOGICALS & BIOLOG Share Price Today

As of 3 Nov 2026, BHARAT IMMUNOLOGICALS & BIOLOG share price is ₹9.19. The stock opened at ₹9.00, compared to its previous close of ₹8.87. During today's trading session, BHARAT IMMUNOLOGICALS & BIOLOG share price moved in the range of ₹8.71 to ₹9.30, with an average price of ₹9.01 for the day. Looking at its last 52-week, the stock has touched a low of ₹7.11 and a high of ₹22.61.

Share price over the last 1 day rose from 9.00 to 9.19, ranging between 8.71 and 9.30.

₹8.71
3.61% up today
₹9.30
1D LOW
1D HIGH

BHARAT IMMUNOLOGICALS & BIOLOG Stock Insights

Stock Performance
UnderperformingUnderperforming Nifty by 46.06 % in last 1 yr
BHARAT IMMUNOLOGICALS & BIOLOG stock performance
Open₹9.00
High₹9.30
Low₹8.71
Prev. close₹8.87
BHARAT IMMUNOLOGICALS & BIOLOG trading activity
Volume14,200
Average traded price₹9.07
Last traded time03:28:21 02 Nov
Last traded quantity25

Circuit
L
H
₹8.28
₹10.10
52-week
L
H
₹7.11
₹22.61
Mkt Cap Cr
38.30

P/E
-2.12

P/B
-4.09

ROA
-9.61%
ROE
-22.95%

ROCE
-11.16%

Quick Ratio
0.35

EV/EBITDA
-6.15

Based on fundamentals, this stock's

Performance: 3 out of 5, Neutral
Performance
Neutral
Bharat Immunolog performance is moderate compared to markets
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Bharat Immunolog appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,195.6245.155.817.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.454.0714.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

BHARAT IMMUNOLOGICALS & BIOLOG Company Background

ISIN
INE994B01014
Sector Market Cap
₹ 38.30 Cr

Bharat Immunologicals and Biologicals Corporation Limited is an India-based biotechnology company. The Company is primarily engaged in the manufacture of oral polio vaccine, zinc tablet, and diarrhea management kit. It operates under various segment, namely oral polio vaccine, zinc tablets, BIB VIT, and BIBSANIT. It is also focused on manufacturing Ready to Use Therapeutic Food (RUTF), which is used for the treatment of malnourishment among various acute malnourished children. The Company is switched over to bivalent oral polio vaccine (bOPV) from trivalent oral polio vaccine (tOPV). It is also diversified into plasma-derived medicines and Oral Cholera vaccines. The Company's manufacturing unit is located at Village Chola, Bulandshahr, Uttar Pradesh, India.

BHARAT IMMUNOLOGICALS & BIOLOG Financial Highlights

  • Revenue: BHARAT IMMUNOLOGICALS & BIOLOG reported revenue of ₹45.67 crore in FY23 vs ₹79.49 crore in FY22. It showed a decrease of 42.55% on a yearly basis.
  • Operating Profit: BHARAT IMMUNOLOGICALS & BIOLOG reported an operating loss of ₹22.27 crore in FY23 vs ₹9.69 crore in FY22. It showed a decrease of 129.82% on a year-on-year basis.
  • Net Profit: BHARAT IMMUNOLOGICALS & BIOLOG reported a net loss of ₹16.64 crore in FY23 vs ₹8.75 crore in FY22. It showed a decrease of 90.17% on a yearly basis.

BHARAT IMMUNOLOGICALS & BIOLOG Quarterly Result Highlights

  • BHARAT IMMUNOLOGICALS & BIOLOG reported revenue of ₹0.16 crore in Sep 2023, compared with ₹0.10 crore in Jun 2023, representing an increase of 60.00% on a quarter-on-quarter (QoQ) basis.
  • BHARAT IMMUNOLOGICALS & BIOLOG reported an operating loss of ₹6.65 crore in Sep 2023, compared with ₹5.97 crore in Jun 2023, representing a decrease of 11.39% on a quarter-on-quarter (QoQ) basis.
  • BHARAT IMMUNOLOGICALS & BIOLOG reported a loss of ₹4.92 crore in Sep 2023, compared with ₹4.59 crore in Jun 2023, reflecting a decrease of 7.19% on a QoQ basis.
  • The earnings per share (EPS) of BHARAT IMMUNOLOGICALS & BIOLOG stood at ₹3.95 during Sep 2023.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
59.25%
FII
0.00%
Other DII
0.00%
Retail and other
40.75%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Jun 20230.00%
Sep 20230.00%
Dec 20230.00%
Mar 20240.00%

BHARAT IMMUNOLOGICALS & BIOLOG Investment Returns

1 day
+3.61%

1 week
+1.10%

1 month
+12.35%

1 year
-54.84%

3 years
-61.69%

5 years
-83.21%

BHARAT IMMUNOLOGICALS & BIOLOG Share Price History

BHARAT IMMUNOLOGICALS & BIOLOG share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹9.00 / ₹9.19
+3.61%
30 Oct 26
₹8.95 / ₹8.87
-0.89%
29 Oct 26
₹9.10 / ₹8.95
+0.79%
28 Oct 26
₹9.40 / ₹8.88
-4.31%
Show more

BHARAT IMMUNOLOGICALS & BIOLOG Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2023Mar 2022Mar 2021Mar 2020
Revenue₹44.61₹78.39₹85.33₹66.84
Other Income₹2.80₹1.10₹1.68₹1.18
Total Revenue₹47.41₹79.49₹87.01₹68.02
Total Expenses₹70.26₹89.18₹111.22₹82.22
Profit Before Tax-₹22.85-₹9.69-₹24.21-₹14.20
Tax-₹5.79-₹0.93-₹6.10-₹3.99
Profit After Tax-₹17.06-₹8.75-₹18.11-₹10.21
EPS - Basic-₹3.95-₹2.03₹1.10-₹2.36
EPS - Diluted-₹3.95-₹2.03₹1.10-₹2.36

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2023Mar 2022Mar 2021Mar 2020
Profit before tax-₹22.85-₹9.69-₹24.21-₹14.20
Income before WC changes-₹16.13-₹4.41₹11.82-₹10.13
Change in Assets₹28.86-₹24.54₹60.63₹2.46
Change in Liabilities-₹1.84-₹13.16-₹60.67₹41.75
Change in WC₹27.02-₹37.70-₹0.04₹44.21
Cash flow from Operations₹10.89-₹42.12₹11.78₹34.08
Cash flow from Investing₹0.46₹0.53₹0.67₹0.91
Cash flow from Financing-₹14.71₹45.00-₹12.20-₹34.41
Total Cash Flow-₹3.36₹3.42₹0.24₹0.58
Cash (Start of the year)₹4.64₹1.23₹0.99₹0.41
Cash (End of the year)₹1.29₹4.64₹1.23₹0.99

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2023Mar 2022Mar 2021Mar 2020
Non-Current Assets₹152.60₹147.30₹70.03₹33.81
Current Assets₹33.06₹65.43₹33.95₹93.02
Total Assets₹185.66₹212.73₹103.99₹126.83
Current Liabilities₹91.44₹101.26₹64.09₹100.71
Net Current Asset-₹58.38-₹35.83-₹30.14-₹7.69
Non-Current Liabilities₹6.42₹6.11₹5.85₹5.65
Equity Capital₹87.80₹105.35₹34.04₹20.47
Total Equity & Liabilities₹185.66₹212.73₹103.99₹126.83
* All values are in INR Crore
BHARAT IMMUNOLOGICALS & BIOLOG market depth
Bid quantityBid priceAsk priceAsk quantity
009.19806
0000
0000
0000
0000
Total bid quantity0
Total ask quantity806
BHARAT IMMUNOLOGICALS & BIOLOG technical summary
Bearish indicators2
Neutral indicators4
Bullish indicators2
OverallNeutral
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict

RSI (14)
33.66
Neutral

ATR (14)
0.6
Neutral

STOCH(9,6)
20.77
Bullish

STOCH RSI (14)
59.42
Neutral

ADX(9)
37.65
Bearish

UO(9)
52.23
Neutral

ROC(12)
-6.63
Bearish

WillR(14)
-82.8
Bullish
Period
Simple value
Exponential vaue

5D
9.03
9.07

10D
9.13
9.15

20D
9.08
9.64

50D
12.22
11.54

100D
14.4
13.43
Volume trend — traded volume by day
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

BHARAT IMMUNOLOGICALS & BIOLOG
Pharmaceuticals
Add Stock
Add Another

BHARAT IMMUNOLOGICALS & BIOLOG Returns Calculator

BHARAT IMMUNOLOGICALS & BIOLOG Share Price FAQs












Please be aware that BHARAT IMMUNOLOGICALS & BIOLOG stock prices are subject to continuous fluctuations due to various factors.